Sanovel İlaç
Murat Caglar has extensive work experience in the field of finance and auditing. Murat currently serves as the Chief Financial Officer at Sanovel Ilaç since September 2022. Prior to this, they were a member of the PAIB Advisory Group at the International Federation of Accountants (IFAC) starting from January 2019.
In 2013, they held multiple roles as an Audit Committee Member at various organizations, including the Family Health and Planning Foundation Turkey, Geyre Foundation, and DenizTemiz Derneği/TURMEPA. These roles focused on gender equality, sponsorship of archaeological excavations, and marine environment protection.
From 2005 to 2022, Murat worked at Koç Holding A.Ş., where they served as the Audit Group Coordinator from January 2009 until August 2022. Murat also held the position of Group Audit Manager from January 2005 to December 2008. Koç Holding A.Ş. is a Fortune 500 company operating in various industries.
In their earlier career, Murat worked at PwC Turkey from 1997 to 2005, starting as an Audit Assistant and eventually becoming an Audit Manager. During their time at PwC, they managed external audit assignments for a diverse range of clients.
Additionally, they played a significant role in the Turkiye Ic Denetim Enstitüsü (TİDE) IIA Turkey, where they served as the Chairman from January 2018 to April 2021, and also as the Vice Chairman from January 2014 to December 2017. TİDE IIA Turkey is an organization providing services to its members in the field of internal auditing.
Overall, Murat Caglar has gained extensive experience in financial management, auditing, and organizational leadership throughout their career.
Murat Caglar attended Bilkent University from 1993 to 1997, where they studied Economics. Murat also holds certifications as a Certified Fraud Examiner and a Certified Public Accountant from the Association of Certified Fraud Examiners and TURMOB, respectively. Additionally, they have completed the "Disruptive Strategy With Clayton Christiensen" course at Harvard Business School.
This person is not in any offices
Sanovel İlaç
Sanovel, which produces at world standards without making any concessions to its principles and quality, was founded by Pharmacist Erol Toksöz. Having set up Ankara Galenos Pharmaceutical Warehouse in 1971, which is a step into the pharmaceutical industry, he purchased Adilna in 1982. He established Sanovel in 1983. Having started its production in Şişli, Sanovel today brings Turkish pharmaceutical industry to the future at modern facilities with an indoor space of 53,000 m2, located on an area of 125,000 m2. Having made a quick and stable improvement since its foundation, Sanovel is one of the leading companies in the pharmaceutical industry. Sanovel Pharmaceutical’s production facility, first laid foundation at İstanbul Silivri Çantaköy in 2001, fully started production as of November 2006. The production site comprises the main production unit, cephalosporin production unit, refining unit, elevated storage and social recreational facility. The production capacity is 227 million units per year. Closely following the developments in the world, Sanovel sets an example for the whole Turkish pharmaceutical industry, with the huge investments it makes in human resources and Research & Development studies.